141 related articles for article (PubMed ID: 22732092)
21. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis.
Qiu M; Xiong W; Liao H; Li F
Gene; 2013 Apr; 518(2):310-5. PubMed ID: 23353010
[TBL] [Abstract][Full Text] [Related]
22. Association of KCNQ1 and KLF14 polymorphisms and risk of type 2 diabetes mellitus: A global meta-analysis.
Wang J; Zhang J; Shen J; Hu D; Yan G; Liu X; Xu X; Pei L; Li Y; Sun C
Hum Immunol; 2014 Apr; 75(4):342-7. PubMed ID: 24486580
[TBL] [Abstract][Full Text] [Related]
23. Association between IGF2BP2 rs4402960 polymorphism and risk of type 2 diabetes mellitus: a meta-analysis.
Jia H; Yu L; Jiang Z; Ji Q
Arch Med Res; 2011 Jul; 42(5):361-7. PubMed ID: 21839790
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
[TBL] [Abstract][Full Text] [Related]
25. Association between IL-1RN gene polymorphisms and susceptibility to ankylosing spondylitis: a large Human Genome Epidemiology review and meta-analysis.
Jin GX; Duan JZ; Guo WL; Li L; Cui SQ; Wang H
Genet Mol Res; 2013 May; 12(2):1720-30. PubMed ID: 23765978
[TBL] [Abstract][Full Text] [Related]
26. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
27. Association of the C242T polymorphism in the NAD(P)H oxidase P22 phox gene with type 2 diabetes mellitus risk: a meta-analysis.
Sun Q; Yin Y; Zhu Z; Yan Z
Curr Med Res Opin; 2014 Mar; 30(3):415-22. PubMed ID: 24156725
[TBL] [Abstract][Full Text] [Related]
28. The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population.
Onuma H; Tabara Y; Kawamoto R; Shimizu I; Kawamura R; Takata Y; Nishida W; Ohashi J; Miki T; Kohara K; Makino H; Osawa H
J Hum Genet; 2010 Sep; 55(9):600-4. PubMed ID: 20574426
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
Yu ZY; Chen LS; Zhang LC; Zhou TB
Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
[TBL] [Abstract][Full Text] [Related]
30. Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus.
Chang YH; Huang CN; Wu CY; Shiau MY
Hum Immunol; 2005 Dec; 66(12):1258-63. PubMed ID: 16690414
[TBL] [Abstract][Full Text] [Related]
31. Correlation of the TCF7L2 (rs7903146) polymorphism with an enhanced risk of type 2 diabetes mellitus: a meta-analysis.
Guan Y; Yan LH; Liu XY; Zhu XY; Wang SZ; Chen LM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706609
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of the association between the rs7903146 polymorphism at the TCF7L2 locus and type 2 diabetes mellitus susceptibility.
Liu XH; Xie CG; An Y; Zhang XX; Wu WB
Genet Mol Res; 2015 Dec; 14(4):16856-62. PubMed ID: 26681031
[TBL] [Abstract][Full Text] [Related]
33. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
[TBL] [Abstract][Full Text] [Related]
35. Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis.
Cugino D; Gianfagna F; Santimone I; de Gaetano G; Donati MB; Iacoviello L; Di Castelnuovo A
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):619-25. PubMed ID: 21315566
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1 gene cluster polymorphisms associated with periodontal disease in type 2 diabetes.
López NJ; Valenzuela CY; Jara L
J Periodontol; 2009 Oct; 80(10):1590-8. PubMed ID: 19792847
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms in type 2 diabetes mellitus: a meta-analysis of 15,059 subjects.
Yin YW; Wang Q; Sun QQ; Hu AM; Liu HL
Diabetes Res Clin Pract; 2015 Mar; 107(3):338-47. PubMed ID: 25648392
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies.
Liu L; Zhuang W; Wang C; Chen Z; Wu XT; Zhou Y
Cytokine; 2010 Jun; 50(3):328-34. PubMed ID: 20363644
[TBL] [Abstract][Full Text] [Related]
39. Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis.
Pan HF; Leng RX; Ye DQ
Lupus; 2011 Aug; 20(9):945-51. PubMed ID: 21636628
[TBL] [Abstract][Full Text] [Related]
40. TIRAP C539T polymorphism contributes to tuberculosis susceptibility: evidence from a meta-analysis.
Liu Q; Li W; Li D; Feng Y; Tao C
Infect Genet Evol; 2014 Oct; 27():32-9. PubMed ID: 25003251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
